|
US5800815A
(en)
|
1903-05-05 |
1998-09-01 |
Cytel Corporation |
Antibodies to P-selectin and their uses
|
|
US5034506A
(en)
|
1985-03-15 |
1991-07-23 |
Anti-Gene Development Group |
Uncharged morpholino-based polymers having achiral intersubunit linkages
|
|
US5235033A
(en)
|
1985-03-15 |
1993-08-10 |
Anti-Gene Development Group |
Alpha-morpholino ribonucleoside derivatives and polymers thereof
|
|
US6309639B1
(en)
|
1991-02-05 |
2001-10-30 |
The Board Of Regents Of The University Of Oklahoma |
Method for inhibiting an inflammatory response using antibodies to P-selectin glycoprotein ligand
|
|
DK0642356T3
(da)
|
1992-05-05 |
2003-08-04 |
Aeres Biomedical Ltd |
Antistoffer mod P-selectin og deres anvendelser
|
|
US5622701A
(en)
|
1994-06-14 |
1997-04-22 |
Protein Design Labs, Inc. |
Cross-reacting monoclonal antibodies specific for E- and P-selectin
|
|
AR013269A1
(es)
|
1997-08-04 |
2000-12-13 |
Scras |
Producto que contiene por lo menos un rna de doble filamento combinado con por lo menos un agente anti-viral, para la utilizacion terapeutica en eltratamiento de una enfermedad viral, en especial de la hepatitis viral
|
|
US6506559B1
(en)
|
1997-12-23 |
2003-01-14 |
Carnegie Institute Of Washington |
Genetic inhibition by double-stranded RNA
|
|
AUPP249298A0
(en)
|
1998-03-20 |
1998-04-23 |
Ag-Gene Australia Limited |
Synthetic genes and genetic constructs comprising same I
|
|
GB9827152D0
(en)
|
1998-07-03 |
1999-02-03 |
Devgen Nv |
Characterisation of gene function using double stranded rna inhibition
|
|
CA2361201A1
(en)
|
1999-01-28 |
2000-08-03 |
Medical College Of Georgia Research Institute, Inc. |
Composition and method for in vivo and in vitro attenuation of gene expression using double stranded rna
|
|
DE19956568A1
(de)
|
1999-01-30 |
2000-08-17 |
Roland Kreutzer |
Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens
|
|
HK1047109A1
(zh)
|
1999-10-15 |
2003-02-07 |
University Of Massachusetts |
作为指定基因干预工具的rna干预轨迹基因
|
|
GB9927444D0
(en)
|
1999-11-19 |
2000-01-19 |
Cancer Res Campaign Tech |
Inhibiting gene expression
|
|
CA2433680A1
(en)
|
2000-12-28 |
2002-08-01 |
Gregory M Arndt |
Double-stranded rna-mediated gene suppression
|
|
EP1709195B1
(en)
|
2003-12-19 |
2014-01-22 |
Novartis Vaccines and Diagnostics, Inc. |
Cell transfecting formulations of small interfering rna, related compositions and methods of making and use
|
|
PT1737891E
(pt)
|
2004-04-13 |
2013-04-16 |
Hoffmann La Roche |
Anticorpos anti p-selectina
|
|
US8945565B2
(en)
|
2006-12-01 |
2015-02-03 |
Selexys Pharmaceuticals Corporation |
Methods of treating inflammatory or thrombotic conditions with anti-P-selectin antibodies
|
|
US20110212096A1
(en)
|
2006-12-01 |
2011-09-01 |
Scott Rollins |
Anti-p-selectin antibodies and methods of their use and identification
|
|
HUE041957T2
(hu)
|
2006-12-01 |
2019-06-28 |
Novartis Ag |
Anti-P-szelektin antitestek és eljárások azok alkalmazására gyulladásos betegségek kezelésére
|
|
WO2009108274A2
(en)
*
|
2008-02-26 |
2009-09-03 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for adeno-associated virus (aav) with hi loop mutations
|
|
PE20100362A1
(es)
|
2008-10-30 |
2010-05-27 |
Irm Llc |
Derivados de purina que expanden las celulas madre hematopoyeticas
|
|
CA3009891C
(en)
|
2009-12-23 |
2020-09-15 |
Novartis Ag |
Lipids, lipid compositions, and methods of using them
|
|
ES2557382T3
(es)
|
2010-07-06 |
2016-01-25 |
Glaxosmithkline Biologicals Sa |
Liposomas con lípidos que tienen un valor de pKa ventajoso para el suministro de ARN
|
|
MX2013002332A
(es)
|
2010-08-31 |
2013-03-18 |
Novartis Ag |
Lipidos apropiados para suministro liposomal del arn que codifica la proteina.
|
|
EP4115875A1
(en)
|
2011-07-06 |
2023-01-11 |
GlaxoSmithKline Biologicals S.A. |
Liposomes having useful n:p ratio for delivery of rna molecules
|
|
PT2768942T
(pt)
|
2011-10-17 |
2020-01-21 |
Massachusetts Inst Technology |
Entrega intracelular
|
|
US9394547B2
(en)
|
2012-01-03 |
2016-07-19 |
City University Of Hong Kong |
Method and apparatus for delivery of molecules to cells
|
|
WO2013103467A1
(en)
|
2012-01-06 |
2013-07-11 |
Alcon Research, Ltd. |
Interfering rna delivery system and uses thereof
|
|
EP2807165B1
(en)
|
2012-01-27 |
2019-05-15 |
Université de Montréal |
Pyrimido[4,5-b]indole derivatives and use thereof in the expansion of hematopoietic stem cells
|
|
MX367100B
(es)
*
|
2012-02-17 |
2019-08-05 |
The Children´S Hospital Of Philadelphia |
Composiciones del vector aav y metodos para su transferencia genetica a celulas, organos y tejidos.
|
|
US10227610B2
(en)
|
2013-02-25 |
2019-03-12 |
Sangamo Therapeutics, Inc. |
Methods and compositions for enhancing nuclease-mediated gene disruption
|
|
CN107879960B
(zh)
|
2013-03-08 |
2021-06-22 |
诺华股份有限公司 |
用于传递活性成分的脂质和脂质组合物
|
|
DK2970948T3
(en)
|
2013-03-15 |
2019-04-08 |
Glaxosmithkline Biologicals Sa |
METHODS OF RNA PURIFICATION
|
|
WO2014150256A1
(en)
|
2013-03-15 |
2014-09-25 |
Global Blood Therapeutics, Inc. |
Compositions and methods for the modulation of hemoglobin (s)
|
|
KR102243597B1
(ko)
|
2013-08-16 |
2021-04-26 |
메사추세츠 인스티튜트 오브 테크놀로지 |
세포로의 선택적 물질 전달
|
|
EP3083556B1
(en)
|
2013-12-19 |
2019-12-25 |
Novartis AG |
Lipids and lipid compositions for the delivery of active agents
|
|
US10426737B2
(en)
|
2013-12-19 |
2019-10-01 |
Novartis Ag |
Lipids and lipid compositions for the delivery of active agents
|
|
WO2015157070A2
(en)
*
|
2014-04-09 |
2015-10-15 |
Editas Medicine, Inc. |
Crispr/cas-related methods and compositions for treating cystic fibrosis
|
|
WO2018071871A1
(en)
|
2016-10-13 |
2018-04-19 |
President And Fellows Of Harvard College |
Compositions and methods for non-myeloablative conditioning
|
|
WO2018091971A1
(en)
*
|
2016-11-15 |
2018-05-24 |
Genomic Vision |
Method for the monitoring of modified nucleases induced-gene editing events by molecular combing
|
|
US20180305719A1
(en)
*
|
2017-04-19 |
2018-10-25 |
The Board Of Trustees Of The University Of Illinois |
Vectors For Integration Of DNA Into Genomes And Methods For Altering Gene Expression And Interrogating Gene Function
|
|
CN111655271B
(zh)
*
|
2017-12-28 |
2025-09-23 |
隆萨销售股份公司 |
用于免疫肿瘤学和抗炎疗法的外来体
|
|
US20190345516A1
(en)
*
|
2018-03-12 |
2019-11-14 |
Musc Foundation For Research Development |
Methods for treating eye disease
|